ArticleFunctional & integrative genomics2025
DDX1 facilitates lenvatinib resistance in hepatocellular carcinoma through regulating ephrin-A3 and activating the Wnt/β-catenin signaling pathway.
Shenglan Huang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.